Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio
Read more here
News
TREVENTIS Corporation Closes $4.4 Million Financing with Wellcome Trust
Read more here
Relmada Therapeutics Inc. Announces Collaboration with the Malvern Consulting Group
Read more here
Jenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037
Read more here
Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal Pharmacokinetic Study
Read more here
Galderma Receives FDA Approval of Mirvaso®
Read more here
Ceptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel
Read more here
Galderma Receives FDA Approval of Mirvaso®
Read more here
Actelion enters into an agreement to acquire privately-held Ceptaris Therapeutics
Read more here
Intezyne Technologies Expands Its Oncology Pipeline Through Strategic Acquisition of Niiki Pharma
Read more here